Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06472713RecruitingPhase 2
Liposomal mitoxantrone with immunotherapy for advanced nasopharyngeal cancer
This trial tests a combination of a chemotherapy drug (mitoxantrone liposome) with an immunotherapy (PD-1 blocker) for people whose nasopharyngeal cancer has come back or spread and hasn't responded to previous treatments. The goal is to see if this combination can shrink tumors or slow cancer growth.
Zhuhai, GuangdongAges 18–70 - NCT06770296RecruitingPhase 1
Finding the best dose of pyrotinib for first-line advanced HER2 breast cancer
This study tests a new way to give pyrotinib, a targeted pill for HER2-positive breast cancer, to people whose cancer has spread or come back and who have not had other treatments for this stage. The goal is to find the best dose to control cancer while managing side effects.
Nanjing, JiangsuAges 18–75 - NCT06233838Recruiting
Hemoperfusion study for kidney patients on dialysis
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
Fuzhou, FujianAges 18 years+ - NCT07482592RecruitingPhase 1
Study of TQB3205 for advanced solid tumors
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07489495RecruitingPhase 3
Belzutifan and zanzalintinib for advanced kidney cancer
This study tests two new drugs, belzutifan and zanzalintinib, for people with advanced kidney cancer that has not responded well to other treatments. The goal is to see if the combination slows down cancer growth.
Marietta, GeorgiaAges 18 years+ - NCT07483827RecruitingPhase 1
Testing CPV-104 safety in healthy people and C3G patients
This trial tests a new drug called CPV-104. First, healthy volunteers will receive a single dose to check safety. Then, people with C3 glomerulopathy (a rare kidney disease) will receive multiple doses to see if it helps and is safe.
ViennaAges 18 years+ - NCT07489131RecruitingPhase 3
Comparing a new macular edema treatment to Eylea HD
This study tests whether a new drug (AVT29) is as safe and effective as the standard treatment Eylea HD for people with diabetic macular edema (DME) — a condition where fluid builds up in the back of the eye due to diabetes. If you have vision loss from DME and haven't had anti-VEGF injections before, you may be able to join.
BudapestAges 18 years+ - NCT07489482RecruitingPhase 1
Comparing SHR-3167 injection bioavailability and safety
This trial tests how a new medicine (SHR-3167) is absorbed by the body and checks for side effects. Healthy volunteers ages 18-55 can join to help researchers understand how this drug works.
Changsha, HunanAges 18–55 - NCT07484217RecruitingPhase 3
Testing solriamfetol for depression with daytime sleepiness
This study tests if the drug solriamfetol can help people with major depression who also feel very tired during the day. It aims to improve both mood and daytime sleepiness.
Tucson, ArizonaAges 18–65 - NCT06581419RecruitingPhase 1/Phase 2
Testing IAP0971 in advanced solid tumors and lung cancer
This trial tests a new drug called IAP0971 for people with advanced solid tumors or a specific type of lung cancer. It may help if your cancer has not responded to other treatments or if you have PD-L1-positive lung cancer that hasn't been treated yet.
Beijing, Beijing MunicipalityAges 18–75 - NCT07487467Recruiting
Stem cell therapy for type 2 diabetes
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
São Jose Do Rio Preto, São PauloAges 18 years+ - NCT07484971Recruiting
Prostate cancer study in Algeria
This study looks at how prostate cancer is found and treated in Algeria. The goal is to learn more about the disease to improve care for future patients.
Adrar, AlgeriaAges 19 years+ - NCT07487428Recruiting
Diet study for early-stage CLL
This study tests whether a whole-food plant-based diet for 4 weeks can affect immune function and metabolism in people with early-stage CLL who have not yet had treatment.
München, BavariaAges 18 years+ - NCT07486791Recruiting
Baduanjin exercise for heart health after heart attack
This study tests whether a gentle exercise called 'Lying-Sitting-Standing' Baduanjin can improve heart and lung function and quality of life in people who have had a heart attack and also have heart failure.
Taiyuan, ShanxiAges Up to 85 years - NCT07482228Recruiting
Long-term outcomes after retinal artery occlusion
This study looks at the long-term health results of people who have a retinal artery occlusion (a blockage in the blood vessels of the eye). It aims to understand what happens over time, which can help guide treatment and care.
Gwangju, GwangjuAges Any age - NCT07487818RecruitingPhase 2/Phase 3
Vagus nerve stimulation with nicotine replacement for quitting smoking
This study tests whether adding a gentle nerve stimulation device to nicotine replacement therapy (like patches or gum) can help people quit smoking more effectively. It may be a new option for those who have struggled to quit before.
Rochester, MinnesotaAges 18 years+ - NCT07488520RecruitingPhase 4
Early sickle cell testing for newborns
This study tests a simple blood test for newborn babies to find sickle cell disease early. If the test shows your baby has it, they can get care right away to stay healthier.
AbidjanAges birth–6 months - NCT07483424Enrolling by invitation
Growth restriction in full-term babies: body composition study
This study looks at how body composition differs in full-term babies who had intrauterine growth restriction. It may help doctors better understand and care for these infants.
LisbonAges 9 months–9 months - NCT07485725Recruiting
Digital tools study for health decisions
This study tests if digital tools can help older adults make better healthcare decisions. You’ll use a website to search for health information and share your thoughts in interviews.
Tallahassee, FloridaAges 60 years+ - NCT07485686Enrolling by invitation
Studying urinary tract infections to improve treatment
This study collects medical data from people with urinary tract infections (UTIs) to help future research and improve how UTIs are treated. You may be eligible if you have symptoms of a UTI now or have had them in the past.
FrankfurtAges 18 years+ - NCT07483177RecruitingPhase 1/Phase 2
Heart study for enlarged aorta
This trial tests a treatment to help people with a mildly enlarged ascending aorta. It aims to slow down growth and prevent future heart problems.
Rochester, MinnesotaAges 18 years+ - NCT07482800Recruiting
Dementia in stories and real-life medical cases
This study looks at how people with early Alzheimer's or mild memory problems understand stories compared to healthy adults. Your participation could help researchers learn more about how dementia affects thinking and language.
New Taipei CityAges 60–85 - NCT07482059RecruitingPhase 1/Phase 2
Combination therapy for advanced liver cancer
This trial tests a combination of treatments for liver cancer that cannot be removed by surgery. It uses a special radiation therapy called Y90 along with other drugs to see if they work better together.
Chengdu, SichuanAges 18–80 - NCT07488572Enrolling by invitationPhase 2
AK112 for advanced clear cell kidney cancer
This study tests a new drug called AK112 (Yiwoxidan Anti) in people with advanced clear cell kidney cancer who cannot take TKI medications. The goal is to see if it is safe and effective.
Guangzhou, GuangdongAges 18–75
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.